Understanding the Mechanism of Action of Secukinumab Using Lesional Hidradenitis Suppurativa Skin Organ Culture
November 2024
in “
Journal of Investigative Dermatology
”
Studysummary Secukinumab reduces immune activity in hidradenitis suppurativa skin.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jidonline.org →